|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
1.400 -0.050 (-3.448%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 1.622% | -1.964% | -0.456% | -14.378% | 3.025% |
| ROAE (%) | 3.516% | -4.922% | -1.178% | -29.412% | 4.767% |
| Return on Capital Employed (%) | 2.263% | -3.000% | -0.727% | -19.931% | 3.473% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 68.826% | 65.315% | 69.638% | 68.200% | 74.394% |
| EBITDA Margin (%) | 21.800% | -12.029% | 5.027% | -86.117% | 27.389% |
| Pre-tax Profit Margin (%) | 15.934% | -22.528% | -8.667% | -97.322% | 14.768% |
| Net Profit Margin (%) | 6.864% | -11.397% | -2.903% | -87.792% | 12.655% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 1.803 X | 1.727 X | 1.511 X | 2.586 X | 3.094 X |
| Quick Ratio (X) | 1.635 X | 1.601 X | 1.375 X | 2.347 X | 2.808 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 40.679% | 53.005% | 55.467% | 53.546% | 36.877% |
| Total Debt / Total Assets (%) | 8.059% | 8.614% | 10.553% | 10.285% | 7.460% |
| Net Debt / Total Assets (%) | -22.551% | -24.832% | -22.204% | -21.253% | -31.741% |
| Total Debt / Shareholders' Funds (%) | 16.026% | 20.749% | 27.467% | 26.360% | 13.054% |
| Long Term Debt / Shareholders' Funds (%) | 12.003% | 17.355% | 21.103% | 18.884% | 10.577% |
| Net Debt / Shareholders' Funds (%) | -44.843% | -59.813% | -57.789% | -54.469% | -55.540% |
| Net Cash / (Debt) ($) | 2.623B | 2.615B | 2.561B | 2.580B | 4.601B |
| Net Cash / (Debt) per share ($) | 0.287 | 0.281 | 0.275 | 0.277 | 0.493 |
| Total Debt / Capital Employed (%) | 11.803% | 12.563% | 16.388% | 12.997% | 9.016% |
| Interest Coverage Ratio (X) | 3.069 X | N/A | 0.401 X | N/A | 5.074 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 231.376 Day | 269.661 Day | 376.060 Day | 347.840 Day | 262.285 Day |
| Receivables Turnover (Day) | 121.989 Day | 95.204 Day | 90.249 Day | 108.881 Day | 64.814 Day |
| Payables Turnover (Day) | 48.510 Day | 47.402 Day | 41.825 Day | 27.167 Day | 12.482 Day |
| Remarks: | Real time quote last updated: 02/04/2026 14:17 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 179,696 |
| %Change | -- |
| EPS / (LPS) | RMB 0.020 |
| NBV Per Share (¥) | RMB 0.640 |